Unit 2: Macrolide Antibiotics, Prodrugs & Antimalarials

March 6, 2026

Semester 6
BP601T

Introduction to Macrolide Antibiotics, Prodrugs & Antimalarials

This unit covers Macrolide antibiotics (Erythromycin and its semi-synthetic derivatives that solved its GI instability), miscellaneous antibiotics (Chloramphenicol — the first fully synthetic antibiotic, and Clindamycin), the important concept of Prodrug design, and a comprehensive study of Antimalarial agents. The antimalarial section covers the life cycle of Plasmodium (etiology) and all major drug classes: 4-Aminoquinolines (Chloroquine), 8-Aminoquinolines (Primaquine), Biguanides, and Artemisinin-based compounds.

Syllabus & Topics

  • 1Macrolide Antibiotics – Structure: Contain a macrocyclic lactone ring (12-16 membered) attached to deoxy sugars. Erythromycin: 14-membered lactone ring + Desosamine (amino sugar, essential for ribosome binding) + Cladinose (neutral sugar). MOA: Bind to 50S ribosomal subunit (23S rRNA) → block translocation step of protein synthesis → bacteriostatic. Spectrum: Gram-positive + atypical pathogens (Mycoplasma, Chlamydia, Legionella).
  • 2Erythromycin – Chemistry & Degradation: Sensitive to acid (stomach acid). In acidic conditions, the C-6 hydroxyl attacks the C-9 ketone → forms 6,9-hemiketal → further dehydration → 6,9:9,12-spiroketal (anhydroerythromycin) → inactive + causes GI side effects (↑motilin receptor agonism). This acid instability is the main clinical limitation → enteric-coated tablets or prodrug esters (erythromycin estolate, erythromycin stearate) used to protect from acid degradation.
  • 3Clarithromycin: 6-O-methyl erythromycin. The C-6 hydroxyl is methylated → CANNOT form 6,9-hemiketal → acid-stable → better oral bioavailability. ↑activity vs H. pylori (used in triple therapy for peptic ulcer), atypical mycobacteria (MAC in AIDS). Fewer GI side effects than erythromycin. Inhibits CYP3A4 → drug interactions.
  • 4Azithromycin: 15-membered ring (methyl-substituted nitrogen inserted between C-9 and C-10 of erythromycin → ring expansion). This N-methyl group prevents internal hemiketal formation → acid-stable. Unique pharmacokinetics: extremely long t½ (68 h), extensive tissue penetration, concentrated ~100x in phagocytes → released at infection site. 3-day course effective (Zithromax Z-Pak). Less CYP3A4 inhibition than Clarithromycin.
  • 5Chloramphenicol (Chloromycetin): First fully synthetic antibiotic produced commercially. Contains a nitrobenzene ring + dichloroacetamide side chain + propanediol with 2 chiral centers (1R,2R is the active/natural threo isomer). MOA: binds 50S ribosome → inhibits peptidyl transferase → bacteriostatic. Broad spectrum. Major ADR: aplastic anemia (rare but fatal, 1:20,000-40,000) — due to the nitro group → restricted use (topical for eye infections, serious infections like typhoid).
  • 6Clindamycin: Semi-synthetic derivative of Lincomycin. Contains a proline derivative linked to a thio-sugar. MOA: binds 50S ribosome (same site as macrolides/chloramphenicol → cannot combine). Excellent activity vs anaerobes (Bacteroides fragilis) and gram-positive cocci. Major ADR: Pseudomembranous colitis (Clostridioides difficile overgrowth). Used topically for acne and systemically for bone/joint infections.
  • 7Prodrugs – Concept: A prodrug is a pharmacologically INACTIVE chemical derivative of a parent drug that, upon biotransformation (enzymatic or chemical), releases the active drug in vivo. Purpose: improve oral bioavailability, reduce toxicity, improve targeting, overcome formulation problems. Two types: Carrier-linked (active drug linked to carrier via ester, amide, etc.) and Bioprecursor (molecular modification that is metabolically converted to active species).
  • 8Prodrug Applications & Examples: (1) Improve oral absorption: Ampicillin → Bacampicillin (ester prodrug, ↑absorption). (2) Reduce GI irritation: Sulindac (inactive sulfoxide → reduced to active sulfide in vivo). (3) Site-specific delivery: Levodopa (crosses BBB → converted to Dopamine in brain). (4) Prolong duration: Fluphenazine decanoate (IM depot injection, slow ester hydrolysis). (5) Improve taste: Chloramphenicol palmitate (tasteless ester → hydrolyzed in GI to active drug).
  • 9Antimalarials – Etiology of Malaria: Caused by Plasmodium species (P. falciparum — most dangerous, P. vivax, P. ovale, P. malariae). Transmitted by female Anopheles mosquito. Life Cycle: Sporozoites (injected by mosquito) → Liver (exo-erythrocytic/tissue schizogony, P. vivax/ovale form dormant hypnozoites) → Merozoites → RBCs (erythrocytic schizogony → trophozoites → schizonts → merozoites released → fever cycles) → Gametocytes (picked up by mosquito → sexual cycle in mosquito).
  • 10Antimalarial Drug Targets: (1) Tissue schizonticides: kill liver-stage parasites (Primaquine — also kills hypnozoites → radical cure of P. vivax/ovale). (2) Blood schizonticides: kill erythrocytic parasites (Chloroquine, Quinine, Mefloquine, Artemisinin — clinical cure). (3) Gametocytocides: kill sexual forms → prevent transmission (Primaquine). (4) Causal prophylactics: prevent infection entirely by killing liver-stage (Proguanil, Pyrimethamine).
  • 114-Aminoquinolines – Chloroquine: Most important antimalarial for 50+ years. Structure: 4-aminoquinoline nucleus + 4-amino group with diethylaminoalkyl side chain. MOA: Concentrates in acidic food vacuole of Plasmodium → inhibits heme polymerase → free heme (toxic to parasite) accumulates → parasite death. SAR: (1) Quinoline nucleus essential. (2) 4-amino group essential. (3) 7-Chloro ↑activity (electron-withdrawing). (4) Side chain with basic nitrogen → ion trapping in acidic vacuole. Resistance: P. falciparum mutations in PfCRT gene → reduced chloroquine accumulation.
  • 12Other Quinoline Antimalarials: Quinine sulfate: natural alkaloid from Cinchona bark, 4-aminoquinoline-methanol, still used for severe/resistant malaria (IV). Amodiaquine: Mannich base derivative of chloroquine, retains activity vs some CQ-resistant strains. Primaquine: 8-aminoquinoline, the ONLY drug that kills hypnozoites (radical cure of P. vivax/ovale relapsing malaria) and gametocytes. ADR: hemolytic anemia in G6PD-deficient patients. Mefloquine: quinoline-methanol, long t½ (21 days), prophylaxis for CQ-resistant areas. Quinacrine: acridine derivative (not true quinoline), largely obsolete.
  • 13Biguanides & Dihydrotriazines – DHFR Inhibitors: Proguanil (Chloroguanide): biguanide, metabolized to Cycloguanil (active triazine metabolite) by CYP2C19. Cycloguanil: potent inhibitor of plasmodial DHFR (dihydrofolate reductase) → blocks folate synthesis → inhibits DNA synthesis. Used prophylactically (often with Atovaquone = Malarone). Slow-acting. Pyrimethamine: diaminopyrimidine, also inhibits DHFR. Used with Sulfadoxine (= Fansidar, synergistic combination targeting two sequential steps in folate pathway).
  • 14Artemisinin-Based Antimalarials: Artemisinin (Qinghaosu): sesquiterpene lactone with endoperoxide bridge from Artemisia annua. MOA: endoperoxide bridge reacts with Fe²⁺ in heme → generates free radicals → damages parasite membranes and proteins → rapid parasite killing. Fastest onset of any antimalarial. Derivatives: Artesunate (water-soluble, IV/IM for severe malaria), Artemether (lipid-soluble, IM). ACT (Artemisinin-based Combination Therapy): artemisinin derivative + longer-acting partner (Lumefantrine, Amodiaquine, Mefloquine) → WHO first-line for P. falciparum. Atovaquone: hydroxynaphthoquinone, inhibits mitochondrial electron transport (cytochrome bc1 complex) in Plasmodium.

Learning Objectives

Macrolide Chemistry: Explain why Erythromycin is acid-unstable and how Clarithromycin and Azithromycin overcome this problem.
Prodrug Design: Define prodrugs and give five examples illustrating different advantages of the prodrug approach.
Malaria Life Cycle: Draw the Plasmodium life cycle and indicate the stage at which each class of antimalarial drug acts.
Chloroquine SAR: Draw Chloroquine and annotate the SAR points for each structural feature.
Artemisinin MOA: Explain how the endoperoxide bridge in Artemisinin is activated and kills the malaria parasite.

Exam Prep Questions

Q1. Why Is Erythromycin Unstable in Acid?

Erythromycin is unstable in acidic conditions such as those in the stomach (pH 1–3). In acid, the hydroxyl group at the C-6 position reacts with the ketone at C-9 to form a 6,9-hemiketal. This intermediate further dehydrates to produce an inactive compound called Anhydroerythromycin (a spiroketal). This degradation not only destroys antibacterial activity but also stimulates motilin receptors in the gastrointestinal tract, causing side effects such as nausea, abdominal cramps, and diarrhea. Structural modifications in derivatives such as Clarithromycin and Azithromycin improve acid stability.

Q2. What Is the Difference Between Clarithromycin and Azithromycin?

Clarithromycin is a 14-membered macrolide derived from erythromycin with a methyl ether substitution at the C-6 hydroxyl group, which increases acid stability. It has a moderate half-life of about 5 hours and significantly inhibits the enzyme CYP3A4, leading to multiple drug interactions. It is particularly useful in the treatment of infections caused by Helicobacter pylori.
Azithromycin differs structurally by the insertion of a nitrogen atom into the lactone ring, producing a 15-membered azalide ring system. It has a very long half-life of around 68 hours, minimal CYP enzyme inhibition, and accumulates extensively in tissues and phagocytes. These properties allow shorter treatment regimens and make it particularly effective for respiratory tract infections and certain sexually transmitted infections.

Q3. Why Is Primaquine the Only Drug That Provides Radical Cure of Plasmodium vivax?

Primaquine is unique because it eliminates dormant liver stages called hypnozoites produced by Plasmodium vivax and Plasmodium ovale. These hypnozoites remain inactive in the liver for months or years and later reactivate, causing malaria relapse. Most antimalarial drugs such as Chloroquine only kill parasites circulating in the bloodstream (erythrocytic stage). Primaquine targets the hepatic forms of the parasite, eliminating the reservoir responsible for relapse and therefore providing a “radical cure.” Because it can cause hemolysis in individuals with Glucose 6 Phosphate Dehydrogenase deficiency, patients must be tested for this condition before treatment.

Q4. What Is a Prodrug? Give an Example.

A Prodrug is a pharmacologically inactive compound that is converted into an active drug after administration through enzymatic or chemical transformation in the body. For example, Bacampicillin is an ester prodrug of Ampicillin. Bacampicillin is more lipophilic and therefore better absorbed from the gastrointestinal tract. Once in the body, esterases rapidly hydrolyze it to release the active antibiotic ampicillin, significantly improving oral bioavailability compared with ampicillin itself.